Michael Shetzline, CMO, SVP & Head of Drug Devt at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 2,077 shares at $12.25 ($25K) on 2021-05-24, disclosed to the SEC on 2021-05-26.
Scheduled sale ($25k) by CMO, SVP & Head of Drug Devt under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| IRWD | SELL | 2024-05-22 | $208K | — | Filing → |
| IRWD | SELL | 2024-02-14 | $1.2M | — | Filing → |
| IRWD | SELL | 2023-05-24 | $209K | — | Filing → |